These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 12056715)
21. Feasibility and therapeutic efficacy of weekly 1-h low-dose paclitaxel infusion for relapsed breast cancer. Kim R; Osaki A; Toge T Oncol Rep; 2003; 10(1):145-50. PubMed ID: 12469161 [TBL] [Abstract][Full Text] [Related]
22. Multi-center study of two dose levels of paclitaxel with carboplatin in locally advanced and metastatic non-small cell lung cancer (NSCLC). Glorieux P; Ortmanns P; Marien S; Degives R; Degraeve D; Potvin M; Grauwels D; Schallier D Anticancer Res; 2001; 21(2B):1487-94. PubMed ID: 11396237 [TBL] [Abstract][Full Text] [Related]
23. Chemotherapy of advanced inoperable non-small cell lung cancer with paclitaxel: a phase II trial. Gatzemeier U; Heckmayer M; Neuhauss R; Schlüter I; von Pawel J; Wagner H; Dreps A Semin Oncol; 1995 Dec; 22(6 Suppl 15):24-8. PubMed ID: 8643966 [TBL] [Abstract][Full Text] [Related]
24. Phase I study of paclitaxel by three-hour infusion: hypotension just after infusion is one of the major dose-limiting toxicities. Tamura T; Sasaki Y; Nishiwaki Y; Saijo N Jpn J Cancer Res; 1995 Dec; 86(12):1203-9. PubMed ID: 8636011 [TBL] [Abstract][Full Text] [Related]
25. Phase I dose-escalation trial of paclitaxel and ifosfamide in patients with advanced non-small cell lung cancer. Shepherd FA; Latreille J; Paul K; Eisenhauer E Semin Oncol; 1996 Dec; 23(6 Suppl 16):84-90. PubMed ID: 9007130 [TBL] [Abstract][Full Text] [Related]
26. Dose-escalated paclitaxel in 1-hour infusion with a fixed dose of cisplatin in previously untreated advanced ovarian cancer: a phase II trial of the Spanish Group for Ovarian Cancer. Cervantes A; Mendiola C; del Campo JM; Massuti B; Casado A; Escobedo A; Moyano A; Ojeda B; Poveda A; Benito D Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-40-S15-43. PubMed ID: 9346221 [TBL] [Abstract][Full Text] [Related]
27. Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer. Seidman AD; Tiersten A; Hudis C; Gollub M; Barrett S; Yao TJ; Lepore J; Gilewski T; Currie V; Crown J J Clin Oncol; 1995 Oct; 13(10):2575-81. PubMed ID: 7595709 [TBL] [Abstract][Full Text] [Related]
28. Phase I study with a weekly 1 h infusion of paclitaxel in heavily pretreated patients with metastatic breast and ovarian cancer. Klaassen U; Wilke H; Strumberg D; Eberhardt W; Korn M; Seeber S Eur J Cancer; 1996 Mar; 32A(3):547-9. PubMed ID: 8814705 [TBL] [Abstract][Full Text] [Related]
29. Phase I trial of a 96 h paclitaxel infusion with filgrastim support in refractory solid tumor patients. Socinski MA; Mudd PN; Radomski KM; Steagall A; Lawrence P; Bernard S; Letrent SP; Gonzalez P; Brouwer KL Anticancer Drugs; 1998 Aug; 9(7):611-9. PubMed ID: 9773805 [TBL] [Abstract][Full Text] [Related]
30. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer. Klaassen U; Wilke H; Seeber S Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897 [TBL] [Abstract][Full Text] [Related]
31. Paclitaxel (Taxol) and docetaxel (Taxotere): active chemotherapeutic agents in lung cancer. Francis PA; Kris MG; Rigas JR; Grant SC; Miller VA Lung Cancer; 1995 Apr; 12 Suppl 1():S163-72. PubMed ID: 7551925 [TBL] [Abstract][Full Text] [Related]
32. Paclitaxel and epirubicin as first-line therapy for patients with metastatic breast cancer. Lück HJ; Du Bois A; Thomssen C; Lisboa B; Untch M; Köhler G; Hecker D Oncology (Williston Park); 1997 Apr; 11(4 Suppl 3):34-7. PubMed ID: 9144689 [TBL] [Abstract][Full Text] [Related]